Trials / Completed
CompletedNCT03564405
Pilot Clinical Trial to Evaluate the UNI-DEB for Unresectable Hepatocellular Carcinoma
A Open, Single-arm, Uncontrolled, Single Center, Pilot Study to Evaluate the Efficacy and Safety of UNI-DEB for Unresectable Hepatocellular Carcinoma
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 10 (actual)
- Sponsor
- Jeil Pharmaceutical Co., Ltd. · Industry
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Not accepted
Summary
Pilot Clinical Trial to Evaluate the Efficacy and Safety of UNI-DEB for Unresectable Hepatocellular Carcinoma
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | UNI-DEB | Applicate the TACE with UNI-DEB to unresectable hepatocellular carcinoma patient |
Timeline
- Start date
- 2016-12-05
- Primary completion
- 2017-03-07
- Completion
- 2017-05-17
- First posted
- 2018-06-20
- Last updated
- 2018-06-21
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT03564405. Inclusion in this directory is not an endorsement.